Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Elana is a specialized medical technology company based in the Netherlands that focuses on advanced neurosurgical and microvascular solutions. The company is best known for the 'Elana Technique,' a laser-assisted, sutureless bypass method that allows neurosurgeons to create new blood flow pathways in the brain without interrupting circulation. Its flagship product, the Elana Surgical Kit, is a CE-marked and FDA-cleared system used globally to treat complex giant aneurysms and cerebral ischemia that are otherwise difficult to manage. Originating as a spin-off from the University Medical Center Utrecht, Elana continues to innovate in the field of microvascular anastomosis, including expanding its technology into cardiac surgery through the Elana Heart initiative.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Elana.